Drug Profile
BY 112
Latest Information Update: 24 Jun 2002
Price :
$50
*
At a glance
- Originator ALTANA Pharma
- Class
- Mechanism of Action Proton pump inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Gastro-oesophageal reflux
Most Recent Events
- 01 May 2002 Discontinued - Phase-I for Gastro-oesophageal reflux in Germany (unspecified route)
- 11 Nov 1999 Phase-I clinical trials for Gastro-oesophageal reflux in Germany (Unknown route)